跳至主要内容
临床试验/NCT07822360
NCT07822360招募中不适用

Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital

Sohag University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among patients diagnosed with acne vulgaris in Sohag university hospital

研究概览

简要总结

The aim of this study is to determine the prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among female patients diagnosed with acne vulgaris in Sohag university hospital

详细描述

A cross-sectional observational study designed to determine the prevalence of polycystic ovary syndrome (PCOS) among patients diagnosed with acne vulgaris attending Sohag University Hospital.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
15 Years 至 49 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients at childbearing age ( 15 - 49 years) (World Health, 2024).
  • Patients clinically diagnosed with acne vulgaris.
  • Clinical diagnosis of Acne vulgaris:
  • o Presence of comedones (open/black and closed/white), inflammatory lesions (papules, pustules, or nodules), with or without post-acne changes such as hyperpigmentation or scarring (Oge et al., 2019).
  • Patients diagnosed with polyendocrine metabolic ovarian syndrome (PMOS) according to the 2023 International Evidence-based Guideline for PCOS diagnosis.
  • Diagnostic criteria for PMOS diagnosis in adults : (Forslund et al., 2024).
  • Diagnosis of PMOS will be based on the presence of at least two of the following three criteria after exclusion of other etiologies:
  • 1. Ovulatory dysfunction:
  • Irregular menstrual cycles or oligo/anovulation.
  • Clinical and/or biochemical hyperandrogenism:
  • Clinical signs such as hirsutism and/or acne, or biochemical evidence of elevated androgen levels.
  • 3. Polycystic ovarian morphology (PCOM):
  • Polycystic ovaries detected by pelvic ultrasound, or elevated anti-Müllerian hormone (AMH) level in adults as an alternative to ultrasound.
  • Most women with PMOS have a combination of hyperandrogenism and irregular cycles, and in these cases there is no need to assess PCOM. In adolescents, both ovulatory dysfunction and hyperandrogenism are mandatory (Forslund et al., 2024).
  • Patients willing to participate and provide informed consent.

排除标准

  • Pregnant women.
  • Lactating mothers
  • Women diagnosed with other acneiform lesions
  • Women on certain drug treatments like oral contraceptive pills, ovarian stimulating drugs and oral hypoglycemic agents like metformin.
  • Patients with incomplete clinical data or who refuse to participate in the study.

研究组 & 干预措施

Patients diagnosed with acne vulgaris

结局指标

主要结局

Prevalence of polyendocrine metabolic ovarian syndrome (PMOS) among patients diagnosed with acne vulgaris in Sohag university hospital

时间窗: Over 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omar Shazly Saleh

Dermatology, Venereology and Andrology resident

Sohag University

研究点 (1)

Loading locations...

相似试验